ArticleCureus2025
High Mortality in the Male Breast Cancer Community: A Report on Its Drivers and a Demand for Change in Healthcare Policy.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMale breast cancer (MBC) is a rare cancer with a high mortality rate. MBC remains a rare but significant health concern in the United States, with ongoing cases and associated mortality. This mortality rate could be attributed to late detection in men as a result of a lack of awareness, gender bias, and stigma around sexual health.
aimsIn relation, the goals of this study are threefold: (i) to shed light on the role late detection may play in mortality in MBC patients; (ii) to highlight the epidemiological factors that contribute to MBC; and (iii) to promote early detection.
methodsQuestionnaires were created and circulated to MBC patients in the United States and their families to garner information on their disease progression. This study was conducted remotely, and data were received from 122 patients who were part of the MBC coalition (now two separate organizations - Male Breast Cancer Happens and Male Breast Cancer Global Alliance).
resultsA total of 41 (85.30%) survey takers had a grade 1 or 2 cancer, indicating that most cancers were slow-growing. However, it was also found that 52 (68%) men were diagnosed at stage 4, indicating delayed detection.
conclusionFor a cancer so rare, it is easy for the poor outcomes that plague those impacted by MBC to go unnoticed. The lack of awareness and screening for MBC leads to late detection and death. Therefore, it is imperative that the system practices screening protocols that promote early detection, thereby changing the current healthcare policy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.